Start with structured public sources
The workflow searches ClinicalTrials.gov and, when relevant, Russian public records. It records study identifiers, status, update date, countries, sites and published criteria.
Other investigator-initiated or institution-specific studies may not be fully represented in a single international registry, so discovery is never treated as exhaustive.
Build a transparent shortlist
Potentially relevant records are screened against available clinical information without presenting a registry match as eligibility. Ambiguities and missing data are made explicit.
A person should not send identifiable records through a general inbox or messenger. Any document route must provide its own privacy terms and secure handling instructions.
Confirm with the research centre
Current recruitment, pre-screening requirements and next steps are verified with the centre. The centre—not a search interface—decides whether formal screening can proceed.
This final confirmation is particularly important when an international record is old, lists multiple countries or has a broad overall recruitment status.
Quick answers
Frequently asked questions
Does MIKA guarantee enrolment?
No. It supports navigation. Eligibility and enrolment are determined by the research centre under the protocol.
Is every Russian study on ClinicalTrials.gov?
No single database is complete for every type of study. Russian permissions and centre-level information may require separate checks.
Evidence base
Primary and authoritative sources
Use the linked source documents for professional or current interpretation.